PARKIN modifies peripheral immune response and increases neuroinflammation in active experimental autoimmune...

Area of Science:

• Neuroimmunology
• Molecular mechanisms of neuroinflammation
• Mitochondrial dynamics and disease

Background:

• Neuroinflammation is a key factor in neurodegenerative diseases.
• The role of mitophagy regulators like Parkin in neuroinflammation is not fully understood.

Purpose of the Study:

• To investigate the impact of Parkin deficiency on neuroinflammation using a mouse model of experimental autoimmune encephalomyelitis (EAE).
• To elucidate the specific immune cell responses and central nervous system pathology associated with the absence of Parkin.

Main Methods:

• Utilized female Parkin knockout (Parkin-/-) and wild-type (WT) mice in an EAE model induced by myelin oligodendrocyte glycoprotein immunization.
• Assessed disease onset and severity, quantified immune cell populations (T cells, monocytes/macrophages, microglia, astrocytes) in spleen and CNS, and analyzed T-cell proliferation and cytokine secretion.
• Examined glial cell numbers and mitochondrial morphology in mice with persistent disease.

Main Results:

• Parkin-/- mice exhibited earlier onset and increased severity of EAE compared to WT controls.
• Parkin deficiency led to elevated CD8αβ+TCRαβ+ T cells, enhanced T-cell proliferation, and altered cytokine profiles in splenocytes.
• Significant infiltration of monocytes/macrophages and activated microglia was observed in the spinal cord of Parkin-/- mice.
• Accumulation of mixed M1/M2 microglia and A1 reactive astrocytes was prominent in the CNS of Parkin-/- mice.
• Mice with persistent disease showed reduced glial cell numbers and abnormal mitochondrial morphology.

Conclusions:

• Parkin plays a crucial role in modulating peripheral immune cell responses and neuroinflammation during EAE.
• Loss of Parkin function exacerbates EAE pathogenesis, suggesting its neuroprotective potential.
• Targeting Parkin may offer novel therapeutic strategies for neuroinflammatory and neurodegenerative disorders.